Rahmouni A, Malinge J M, Schwartz A, Leng M
Centre de Biophysique Moléculaire, Orleans, France.
J Biomol Struct Dyn. 1985 Oct;3(2):363-75. doi: 10.1080/07391102.1985.10508423.
The importance of the base composition and of the conformation of nucleic acids in the reaction with the drug cis-diamminedichloroplatinum(II) has been studied by competition experiments between the drug and several double-stranded polydeoxyribonucleotides. Binding to poly(dG).poly(dC) is larger than to poly (dG-dC).poly(dG-dC). There is no preferential binding in the competition between poly(dG-dC).poly(dG-dC), poly(dA-dC).poly(dG-dT) and poly(dA-dG).poly(dC-dT). In the competition between poly(dG-dC).poly (dG-dC) (B conformation) and poly(dG-br5dC).poly(dG-br5dC) (Z conformation), the drug binds equally well to both polynucleotides. In natural DNA, modification of guanine residues in (GC)n.(GC)n sequences by the drug has been revealed by the inhibition of cleavage of these sequences by the restriction enzyme BssHII. By means of antibodies to platinated poly(dG-dC), it is shown that some of the adducts formed in platinated poly(dG-dC) are also formed in platinated pBR322 DNA. The type of adducts recognized the antibodies is not known. Thin layer chromatography of the products after chemical and enzymatic hydrolysis of platinated poly(dG-dC) suggests that interstrand cross-links are formed. Finally, the conformations of poly(dG-dC) modified either by cis-diamminedichloroplatinum(II) or by trans-diamminedichloroplatinum (II) have been compared by circular dichroism. Both the cis-isomer and the trans-isomer stabilize the Z conformation when they bind to poly(dG-m5dC) in the Z conformation. When they bind to poly(dG-m5dC) in the B conformation, the conformations of poly(dG-m5dC) modified by the cis or the trans-isomer are different. Moreover, the cis-isomer facilitates the B form-Z form transition of the unplatinated regions while the trans-isomer makes it more difficult.
通过药物与几种双链聚脱氧核糖核苷酸之间的竞争实验,研究了核酸的碱基组成和构象在与顺二氨二氯铂(II)反应中的重要性。与聚(dG)·聚(dC)的结合大于与聚(dG-dC)·聚(dG-dC)的结合。在聚(dG-dC)·聚(dG-dC)、聚(dA-dC)·聚(dG-dT)和聚(dA-dG)·聚(dC-dT)之间的竞争中没有优先结合。在聚(dG-dC)·聚(dG-dC)(B构象)和聚(dG-br5dC)·聚(dG-br5dC)(Z构象)之间的竞争中,药物与两种多核苷酸的结合效果相同。在天然DNA中,通过限制酶BssHII对这些序列切割的抑制作用,揭示了药物对(GC)n·(GC)n序列中鸟嘌呤残基的修饰。借助针对铂化聚(dG-dC)的抗体表明,铂化聚(dG-dC)中形成的一些加合物在铂化pBR322 DNA中也会形成。抗体识别的加合物类型尚不清楚。铂化聚(dG-dC)经化学和酶水解后的产物的薄层色谱表明形成了链间交联。最后,通过圆二色性比较了顺二氨二氯铂(II)或反二氨二氯铂(II)修饰的聚(dG-dC)的构象。当顺式异构体和反式异构体与处于Z构象的聚(dG-m5dC)结合时,它们都会稳定Z构象。当它们与处于B构象的聚(dG-m5dC)结合时,顺式或反式异构体修饰的聚(dG-m5dC)的构象不同。此外,顺式异构体促进了未铂化区域的B型-Z型转变,而反式异构体则使其更难发生。